Oral Semaglutide 25 mg Versus Orforglipron 36 mg in Obesity: A Population-Adjusted Indirect Treatment Comparison.

Saved in:
Bibliographic Details
Title: Oral Semaglutide 25 mg Versus Orforglipron 36 mg in Obesity: A Population-Adjusted Indirect Treatment Comparison.
Authors: Michalak W; Novo Nordisk Inc., Plainsboro, New Jersey, USA., Bøg M; Novo Nordisk A/S, Søborg, Denmark., Bendixen T; Novo Nordisk A/S, Søborg, Denmark., Chowdhury R; Petauri Evidence, Bicester, UK., Cowley P; Petauri Evidence, Bicester, UK., Laugesen C; Novo Nordisk A/S, Søborg, Denmark., Rathor N; Novo Nordisk A/S, Søborg, Denmark., Kushner RF; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2026 Aug; Vol. 28 (8), pp. 7247-7256. Date of Electronic Publication: 2026 Jun 01.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42225305
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Oral Semaglutide 25 mg Versus Orforglipron 36 mg in Obesity: A Population-Adjusted Indirect Treatment Comparison.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Michalak+W%22">Michalak W</searchLink>; Novo Nordisk Inc., Plainsboro, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Bøg+M%22">Bøg M</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Bendixen+T%22">Bendixen T</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Chowdhury+R%22">Chowdhury R</searchLink>; Petauri Evidence, Bicester, UK.<br /><searchLink fieldCode="AU" term="%22Cowley+P%22">Cowley P</searchLink>; Petauri Evidence, Bicester, UK.<br /><searchLink fieldCode="AU" term="%22Laugesen+C%22">Laugesen C</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Rathor+N%22">Rathor N</searchLink>; Novo Nordisk A/S, Søborg, Denmark.<br /><searchLink fieldCode="AU" term="%22Kushner+RF%22">Kushner RF</searchLink>; Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100883645%22">Diabetes, obesity & metabolism</searchLink> [Diabetes Obes Metab] 2026 Aug; Vol. 28 (8), pp. 7247-7256. <i>Date of Electronic Publication: </i>2026 Jun 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100883645 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1463-1326 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214628902%22">14628902 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Obes Metab <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42225305
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/dom.70919
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 7247
    Titles:
      – TitleFull: Oral Semaglutide 25 mg Versus Orforglipron 36 mg in Obesity: A Population-Adjusted Indirect Treatment Comparison.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Michalak W
      – PersonEntity:
          Name:
            NameFull: Bøg M
      – PersonEntity:
          Name:
            NameFull: Bendixen T
      – PersonEntity:
          Name:
            NameFull: Chowdhury R
      – PersonEntity:
          Name:
            NameFull: Cowley P
      – PersonEntity:
          Name:
            NameFull: Laugesen C
      – PersonEntity:
          Name:
            NameFull: Rathor N
      – PersonEntity:
          Name:
            NameFull: Kushner RF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2026 Aug
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1463-1326
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Diabetes, obesity & metabolism
              Type: main
ResultId 1